Discovers and develops immunologically based therapeutic anticancer products. Includes progress of clinical trials, and data for investors from company based in Seattle, Washington. (Nasdaq: DNDN)

Visits
349
Added
Nov 25, 2024
Rating
(16)
Rate This Site
QR Code
QR code Download PNG
Embed Badge
Place this code on your website to show you're listed here.
Get the best links delivered weekly — hand-picked from 1,200,810 resources